Novo Nordisk & OpenAI Partnership: Can ChatGPT Accelerate the Next Weight-Loss Blockbuster?
4.30.2026 copyright@uptown Novo Nordisk is leveraging OpenAI’s generative models to navigate the massive biological datasets required to discover the next generation of cardiometabolic treatments. The $500 Billion Bet on Artificial Intelligence Novo Nordisk, the Danish giant behind Wegovy and Ozempic, has officially entered a strategic collaboration with OpenAI. This partnership aims to integrate advanced AI … Read more